Health Condition 1: B86- Scabies
Conditions
Interventions
Intervention1: SPINOSAD 0.9% TOPICAL SOLUTION IN SCABIES: Spinosad 0.9% Topical Solution is a prescription medication used for the treatment of scabies. It contains Spinosad, a naturally derived insec
Sponsors
nil
Eligibility
Inclusion criteria
Inclusion criteria: Patients aged 5 years or older, either gender with active scabies infestation showing the presence of scabies inflammatory lesions (papules, pustules, vesicles, excoriations), pruritus and confirmed with burrows or mite or eggs in dermatoscopy. Patient (or their legal guardians) are willing to give the informed consent/ assent to participate in the study
Exclusion criteria
Exclusion criteria: Pretreatment with topical or oral scabicide in the previous 4 weeks. Use of topical steroids or topical immunosuppressives within 2 weeks. Patients with special forms of scabies like nodular, crusted scabies. Patients having scabies with secondary infection or eczematization and coexisting dermatological disease that could interfere with the diagnosis and subsequent monitoring of scabies. Patients with immunodeficiency or severe systemic disease. Pregnant, planning for pregnancy during the study and lactating females. Patients with known hypersensitivity to the drugs.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Proportion of subjects within each treatment group showingcomplete clinical cure defined as reduction in both the number of lesions as well as the grade of pruritus by more than or equal to 50% and negative dermatoscopy.Timepoint: Dat 14 | — |
Secondary
| Measure | Time frame |
|---|---|
| Proportion of patients showing reduced number of lesions/ symptoms. Proportion of patients showing recurrence of lesions Proportion of patients with persistence of lesions/symptoms Dermatology Life Quality Index Timepoint: Day 14 Day 28 Day 14 Day 14 | — |
Countries
India
Contacts
Public ContactDr Shashi Kumar B M
Mandya Institute Of Medical Sciences
Outcome results
None listed